PPAR-γ Activation As an Anti-inflammatory Therapy for Respiratory Virus Infections

The nuclear receptor superfamily: the second decade

Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90199-x · Cited by 6,964 · see citing works

Interleukin-10 and the Interleukin-10 Receptor

Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737 · see citing works

Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism

Desvergne, B., & Wahli, W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.5.0380 · Cited by 3,079 · see citing works

The Continuing Epidemics of Obesity and Diabetes in the United States

Mokdad, A. H. (2001) · JAMA · doi:10.1001/jama.286.10.1195 · Cited by 2,730 · see citing works

mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.Preprint

Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I., & Spiegelman, B. M. (1994) · Genes & Development · doi:10.1101/gad.8.10.1224 · Cited by 2,182 · see citing works

Fat and Beyond: The Diverse Biology of PPARγ

Tontonoz, P., & Spiegelman, B. M. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.77.061307.091829 · Cited by 2,085 · see citing works

Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia.

de Jong, M. D., Simmons, C. P., Thanh, T. T., Hien, V. M., Smith, G. J. D., Chau, T. N. B., Hoang, D. M., Van Vinh Chau, N., Khanh, T. H., Dong, V. C., et al. (2006) · Nature Medicine · doi:10.1038/nm1477 · Cited by 1,858 · see citing works

Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009

Jain, S., Kamimoto, L., Bramley, A. M., Schmitz, A. M., Benoit, S. R., Louie, J., Sugerman, D. E., Druckenmiller, J. K., Ritger, K. A., Chugh, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906695 · Cited by 1,700 · see citing works

Host Defense Mechanisms Triggered by Microbial Lipoproteins Through Toll-Like Receptors

Brightbill, H. D., Libraty, D. H., Krutzik, S. R., Yang, R., Belisle, J. T., Bleharski, J. R., Maitland, M. L., Norgard, M. V., Plevy, S. E., Smale, S. T., et al. (1999) · Science · doi:10.1126/science.285.5428.732 · Cited by 1,659 · see citing works

Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2

Serbina, N. V., & Pamer, E. G. (2006) · Nature Immunology · doi:10.1038/ni1309 · Cited by 1,658 · see citing works

A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ

Pascual, G., Fong, A. L., Ogawa, S., Gamliel, A., Li, A. C., Perissi, V., Rose, D. W., Willson, T. M., Rosenfeld, M. G., & Glass, C. K. (2005) · Nature · doi:10.1038/nature03988 · Cited by 1,251 · see citing works

Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism

Desvergne, B. (1999) · Endocrine Reviews · doi:10.1210/er.20.5.649 · Cited by 1,251 · see citing works

TNF/iNOS-Producing Dendritic Cells Mediate Innate Immune Defense against Bacterial Infection

Serbina, N. V., Salazar‐Mather, T. P., Biron, C. A., Kuziel, W. A., & Pamer, E. G. (2003) · Immunity · doi:10.1016/s1074-7613(03)00171-7 · Cited by 1,174 · see citing works

Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?

Cheung, C., Poon, L., Lau, A., Luk, W., Lau, Y., Shortridge, K., Gordon, S., Guan, Y., & Peiris, J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11772-7 · Cited by 889 · see citing works

Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase

Huang, J. T., Welch, J. S., Ricote, M., Binder, C. J., Willson, T. M., Kelly, C., Witztum, J. L., Funk, C. D., Conrad, D. J., & Glass, C. K. (1999) · Nature · doi:10.1038/22572 · Cited by 854 · see citing works

Thiazolidinedione Use, Fluid Retention, and Congestive Heart Failure

Nesto, R. W., Bell, D. S. H., Bonow, R. O., Fonseca, V. A., Grundy, S. M., Horton, E. S., Winter, M. L., Porte, D., Semenkovich, C. F., Smith, S. E., et al. (2003) · Circulation · doi:10.1161/01.cir.0000103683.99399.7e · Cited by 831 · see citing works

Dynamic Imaging of T Cell-Dendritic Cell Interactions in Lymph Nodes

Stoll, S., Delon, J., Brotz, T. M., & Germain, R. N. (2002) · Science · doi:10.1126/science.1071065 · Cited by 718 · see citing works

Sulfated Glycans Stimulate Endocytosis of the Cellular Isoform of the Prion Protein, PrPC, in Cultured Cells

Shyng, S., Lehmann, S., Moulder, K. L., & Harris, D. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.50.30221 · Cited by 704 · see citing works

Involvement of Toll-like Receptor 3 in the Immune Response of Lung Epithelial Cells to Double-stranded RNA and Influenza A Virus

Guillot, L., Le Goffic, R., Bloch, S., Escriou, N., Akira, S., Chignard, M., & Si-Tahar, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410592200 · Cited by 689 · see citing works

H5N1 and 1918 Pandemic Influenza Virus Infection Results in Early and Excessive Infiltration of Macrophages and Neutrophils in the Lungs of Mice

Perrone, L. A., Plowden, J., García‐Sastre, A., Katz, J. M., & Tumpey, T. M. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000115 · Cited by 623 · see citing works

Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10

Sun, J., Madan, R., Karp, C. L., & Braciale, T. J. (2009) · Nature Medicine · doi:10.1038/nm.1929 · Cited by 616 · see citing works

PPARs and molecular mechanisms of transrepression

Ricote, M., & Glass, C. K. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.02.013 · Cited by 567 · see citing works

Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms

Straus, D. S., & Glass, C. K. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.09.003 · Cited by 553 · see citing works

Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus

Kash, J. C., Tumpey, T. M., Proll, S. C., Carter, V., Perwitasari, O., Thomas, M. J., Basler, C. F., Palese, P., Taubenberger, J. K., García-Sastre, A., et al. (2006) · Nature · doi:10.1038/nature05181 · Cited by 551 · see citing works

Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages.

Holt, P. G., Oliver, J., Bilyk, N., McMenamin, C., McMenamin, P. G., Kraal, G., & Thepen, T. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.2.397 · Cited by 531 · see citing works

Regulation of immunological homeostasis in the respiratory tract

Holt, P. G., Strickland, D. H., Wikström, M. E., & Jahnsen, F. L. (2008) · Nature Reviews Immunology · doi:10.1038/nri2236 · Cited by 528 · see citing works

Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator–activated receptor-γ

Rousseaux, C., Lefebvre, B., Dubuquoy, L., Lefèbvre, P., Romano, O., Auwerx, J. H., METZGER, D., Wahli, W., Desvergne, B., Naccari, G. C., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041948 · Cited by 528 · see citing works

Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells

Chan, M., Cheung, C., Chui, W., Tsao, S., Nicholls, J., Chan, Y., Chan, R., Long, H., Poon, L., Guan, Y., et al. (2005) · Respiratory Research · doi:10.1186/1465-9921-6-135 · Cited by 510 · see citing works

Loss of integrin αvβ6-mediated TGF-β activation causes Mmp12-dependent emphysema

Morris, D. G., Huang, X., Kaminski, N., Wang, Y., Shapiro, S. D., Dolganov, G., Glick, A. B., & Sheppard, D. (2003) · Nature · doi:10.1038/nature01413 · Cited by 500 · see citing works

Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis.

Nicholson, S., Bonecini-Almeida, M. D. G., Silva, J. R. L. E., Nathan, C., Xie, Q. W., Mumford, R. A., Weidner, J. R., Calaycay, J. R., Geng, J., Boéchat, N., et al. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.5.2293 · Cited by 497 · see citing works

The Nuclear Receptor PPARγ and Immunoregulation: PPARγ Mediates Inhibition of Helper T Cell Responses

Clark, R. B., Bishop‐Bailey, D., Estrada-Hernandez, T., Hla, T., Puddington, L., & Padula, S. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.3.1364 · Cited by 465 · see citing works

Complications of Viral Influenza

Rothberg, M. B., Haessler, S. D., & Brown, R. B. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.10.040 · Cited by 456 · see citing works

CCR2+ Monocyte-Derived Dendritic Cells and Exudate Macrophages Produce Influenza-Induced Pulmonary Immune Pathology and Mortality

Lin, K. L., Suzuki, Y. A., Nakano, H., Ramsburg, E. A., & Gunn, M. D. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2562 · Cited by 441 · see citing works

Pulmonary Pathologic Findings of Fatal 2009 Pandemic Influenza A/H1N1 Viral Infections

Gill, J. R., Sheng, Z.-M., Ely, S. F., Guinee, D. G., Beasley, M. B., Suh, J., Deshpande, C., Mollura, D. J., Morens, D. M., Bray, M., et al. (2010) · Archives of Pathology & Laboratory Medicine · doi:10.5858/134.2.235 · Cited by 426 · see citing works

TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection

Aldridge, J. R., Moseley, C. E., Boltz, D. A., Negovetich, N. J., Reynolds, C., Franks, J., Brown, S. A., Doherty, P. C., Webster, R. G., & Thomas, P. G. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900655106 · Cited by 425 · see citing works

Alveolar macrophage elimination in vivo is associated with an increase in pulmonary immune response in mice.

Thepen, T., van Rooijen, N., & Kraal, G. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.170.2.499 · Cited by 421 · see citing works

Interaction of the peroxisome-proliferator-activated receptor and retinoid X receptor.

Gearing, K. L., Göttlicher, M., Teboul, M., Widmark, E., & Gustafsson, J.-Α. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.4.1440 · Cited by 395 · see citing works

Activation of PPAR γ and δ by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease

Bassaganya-Riera, J., Reynolds, K., Martino‐Catt, S. J., Cui, Y., Hennighausen, L. G., Gonzalez, F. J., Rohrer, J., Uribe-Benninghoff, A., & Hontecillas, R. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.06.049 · Cited by 393 · see citing works

Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge.

Bender, B. S., Croghan, T. W., Zhang, L., & Small, P. A. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.175.4.1143 · Cited by 383 · see citing works

Tc17, a Unique Subset of CD8 T Cells That Can Protect against Lethal Influenza Challenge

Hamada, H., García-Hernández, M. D. L. L., Reome, J. B., Misra, S. K., Strutt, T. M., McKinstry, K. K., Cooper, A. M., Swain, S. L., & Dutton, R. W. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801814 · Cited by 382 · see citing works

Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand

Herold, S., Steinmueller, M., von Wulffen, W., Cakarova, L., Pinto, R., Pleschka, S., Mack, M., Kuziel, W. A., Corazza, N., Brunner, T., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080201 · Cited by 376 · see citing works

Influenza Virus PB1-F2 Protein Induces Cell Death through Mitochondrial ANT3 and VDAC1

Zamarin, D., García‐Sastre, A., Xiao, X., Wang, R., & Palese, P. (2005) · PLoS Pathogens · doi:10.1371/journal.ppat.0010004 · Cited by 376 · see citing works

Role of Host Cytokine Responses in the Pathogenesis of Avian H5N1 Influenza Viruses in Mice

Szretter, K. J., Gangappa, S., Lu, X., Smith, C. S., Shieh, W., Zaki, S. R., Sambhara, S. R., Tumpey, T. M., & Katz, J. M. (2006) · Journal of Virology · doi:10.1128/jvi.02336-06 · Cited by 373 · see citing works

Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus

Baskin, C. R., Bielefeldt-Ohmann, H., Tumpey, T. M., Sabourin, P. J., Long, J. P., García-Sastre, A., Tolnay, A.-E., Albrecht, R., Pyles, J. A., Olson, P. H., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813234106 · Cited by 361 · see citing works

CD4 Effector T Cell Subsets in the Response to Influenza

Román, E., Miller, E., Harmsen, A. G., Wiley, J., von Andrian, U. H., Huston, G. E., & Swain, S. L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20021052 · Cited by 327 · see citing works

PPARγ agonists inhibit TGF-β induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis

Burgess, H. A., Daugherty, L. E., Thatcher, T. H., Lakatos, H. F., Ray, D. M., Redonnet, M. R., Phipps, R. P., & Sime, P. J. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00383.2004 · Cited by 318 · see citing works

Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus

Zheng, B.-J., Chan, K.-W., Lin, Y.-P., Zhao, G.-Y., Chan, C., Zhang, H.-J., Chen, H.-L., Wong, S. S. Y., Lau, S. K. P., Woo, P. C. Y., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711942105 · Cited by 302 · see citing works

Neutrophils Ameliorate Lung Injury and the Development of Severe Disease during Influenza Infection

Tate, M. D., Deng, Y., Jones, J. E. C., Anderson, G. P., Brööks, A. G., & Reading, P. C. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902497 · Cited by 296 · see citing works

Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection

Salomon, R., Hoffmann, E., & Webster, R. G. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705289104 · Cited by 265 · see citing works

Modulation of Dendritic Cell Trafficking to and from the Airways

Jakubzick, C., Tacke, F., Llodrá, J., van Rooijen, N., & Randolph, G. J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.6.3578 · Cited by 251 · see citing works

Peroxisome Proliferator–activated Receptors α and γ Down-regulate Allergic Inflammation and Eosinophil Activation

Woerly, G., Honda, K., Loyens, M., Papin, J.-P., Auwerx, J. H., Staels, B., Capron, M., & Dombrowicz, D. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021384 · Cited by 245 · see citing works

Resistance to and Recovery from Lethal Influenza Virus Infection in B Lymphocyte–deficient Mice

Graham, M. B., & Braciale, T. J. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.12.2063 · Cited by 241 · see citing works

Statin therapy is associated with fewer deaths in patients with bacteraemia

Krüger, P., Fitzsimmons, K., Cook, D., Jones, M., & Nimmo, G. R. (2005) · Intensive Care Medicine · doi:10.1007/s00134-005-2859-y · Cited by 234 · see citing works

Rosiglitazone for Active Ulcerative Colitis: A Randomized Placebo-Controlled Trial

Lewis, J. D., Lichtenstein, G. R., Deren, J. J., Sands, B. E., Hanauer, S. B., Katz, J. A., Lashner, B. A., Present, D. H., Chuai, S., Ellenberg, J. H., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.12.012 · Cited by 229 · see citing works

Protective immunity and susceptibility to infectious diseases: lessons from the 1918 influenza pandemic

Ahmed, R., Oldstone, M. B. A., & Palese, P. (2007) · Nature Immunology · doi:10.1038/ni1530 · Cited by 227 · see citing works

Alveolar Epithelial Cells Direct Monocyte Transepithelial Migration upon Influenza Virus Infection: Impact of Chemokines and Adhesion Molecules

Herold, S., von Wulffen, W., Steinmueller, M., Pleschka, S., Kuziel, W. A., Mack, M., Srivastava, M., Seeger, W., Maus, U. A., & Lohmeyer, J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1817 · Cited by 216 · see citing works

Activation, Differentiation, and Migration of Naive Virus-Specific CD8+ T Cells during Pulmonary Influenza Virus Infection

Lawrence, C. W., & Braciale, T. J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.1209 · Cited by 204 · see citing works

Dendritic Cell Immunogenicity Is Regulated by Peroxisome Proliferator-Activated Receptor γ

Nencioni, A., Grünebach, F., Zobywlaski, A., Denzlinger, C., Brugger, W., & Brossart, P. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.3.1228 · Cited by 200 · see citing works

Phosphorylation of PPARs: from molecular characterization to physiological relevance

Diradourian, C., Girard, J. R., & Pégorier, J. P. (2004) · Biochimie · doi:10.1016/j.biochi.2004.11.010 · Cited by 179 · see citing works

A novel PPARγ gene therapy to control inflammation associated with inflammatory bowel disease in a murine model

Katayama, K., Wada, K., Nakajima, A., Mizuguchi, H., Hayakawa, T., Nakagawa, S., Kadowaki, T., Nagai, R., Kamisaki, Y., Blumberg, R. S., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00262-2 · Cited by 176 · see citing works

Tumor necrosis factor and interleukin 1 decrease RXRα, PPARα, PPARγ, LXRα, and the coactivators SRC-1, PGC-1α, and PGC-1β in liver cells

Kim, M. S., Sweeney, T. R., Shigenaga, J. K., Chui, L. G., Moser, A., Grunfeld, C., & Feingold, K. R. (2007) · Metabolism · doi:10.1016/j.metabol.2006.10.007 · Cited by 168 · see citing works

Peroxisome Proliferator-Activated Receptor γ Is Required for Regulatory CD4+ T Cell-Mediated Protection against Colitis

Hontecillas, R., & Bassaganya-Riera, J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.2940 · Cited by 166 · see citing works

Innate immune control and regulation of influenza virus infections

McGill, J. L., Heusel, J. W., & Legge, K. L. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0509368 · Cited by 166 · see citing works

The role of neutrophils in the upper and lower respiratory tract during influenza virus infection of mice

Tate, M. D., Brööks, A. G., & Reading, P. C. (2008) · Respiratory Research · doi:10.1186/1465-9921-9-57 · Cited by 163 · see citing works

Antiinflammatory Roles of Peroxisome Proliferator–activated Receptor γ in Human Alveolar Macrophages

Asada, K., Sasaki, S., Suda, T., Chida, K., & Nakamura, H. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200207-740oc · Cited by 163 · see citing works

Decoding Transcriptional Programs Regulated by PPARs and LXRs in the Macrophage

Ricote, M., Valledor, A. F., & Glass, C. K. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000103951.67680.b1 · Cited by 162 · see citing works

Induction of Proinflammatory Cytokines in Primary Human Macrophages by Influenza A Virus (H5N1) Is Selectively Regulated by IFN Regulatory Factor 3 and p38 MAPK

Hui, K. P. Y., Lee, S. M. Y., Cheung, C. Y., Ng, I. H. Y., Poon, L. L. M., Guan, Y., Ip, N. Y., Lau, A. S. Y., & Peiris, M. J. S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.2.1088 · Cited by 158 · see citing works

Pandemic Influenza: A Potential Role for Statins in Treatment and Prophylaxis

Fedson, D. S. (2006) · Clinical Infectious Diseases · doi:10.1086/505116 · Cited by 156 · see citing works

Activation of PPARγ Specifies a Dendritic Cell Subtype Capable of Enhanced Induction of iNKT Cell Expansion

Szatmári, I., Gogolák, P., Im, J. S., Dezsö, B., Rajnavölgyi, É., & Nagy, L. (2004) · Immunity · doi:10.1016/j.immuni.2004.06.003 · Cited by 152 · see citing works

Lung epithelium as a sentinel and effector system in pneumonia – molecular mechanisms of pathogen recognition and signal transduction

Hippenstiel, S., Opitz, B., Schmeck, B., & Suttorp, N. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-97 · Cited by 152 · see citing works

PPAR‐α and ‐γ but not ‐δ agonists inhibit airway inflammation in a murine model of asthma: in vitro evidence for an NF‐κB‐independent effect

Trifilieff, A., Bench, A., Hanley, M., Bayley, D., Campbell, E. M., & Whittaker, P. A. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705232 · Cited by 148 · see citing works

Influenza A Virus Accelerates Neutrophil Apoptosis and Markedly Potentiates Apoptotic Effects of Bacteria

Colamussi, M. L., White, M. R., Crouch, E. C., & Hartshorn, K. L. (1999) · Blood · doi:10.1182/blood.v93.7.2395 · Cited by 146 · see citing works

Activation of cytokine genes in T cells during primary and secondary murine influenza pneumonia.

Carding, S. R., Allan, W., McMickle, A., & Doherty, P. C. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.177.2.475 · Cited by 145 · see citing works

Peroxisome Proliferator-Activated Receptor γ (PPARγ) and Immunoregulation: Enhancement of Regulatory T Cells through PPARγ-Dependent and -Independent Mechanisms

Wohlfert, E. A., Nichols, F. C., Nevius, E., & Clark, R. B. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.7.4129 · Cited by 139 · see citing works

PPARγ regulates the function of human dendritic cells primarily by altering lipid metabolism

Szatmári, I., Törőcsik, D., Agostini, M., Nagy, T., Gurnell, M., Barta, E., Chatterjee, K., & Nagy, L. (2007) · Blood · doi:10.1182/blood-2007-06-096222 · Cited by 133 · see citing works

Peroxisome Proliferator-Activated Receptor-γ Is Deficient in Alveolar Macrophages from Patients with Alveolar Proteinosis

Bonfield, T. L., Farver, C. F., Barna, B. P., Malur, A., Abraham, S., Raychaudhuri, B., Kavuru, M. S., & Thomassen, M. J. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0148oc · Cited by 132 · see citing works

Peroxisome proliferator-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-1-directed migration of monocytes

Kintscher, U., Goetze, S., Wakino, S., Kim, S., Nagpal, S., Chandraratna, R. A. S., Graf, K., Fleck, E., Hsueh, W. A., & Law, R. E. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00461-1 · Cited by 131 · see citing works

Peroxisome Proliferator–Activated Receptor-γ Regulates Airway Epithelial Cell Activation

Wang, A. C. C., Dai, X., Luu, B. T., & Conrad, D. J. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.24.6.4376 · Cited by 127 · see citing works

Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity

Guillonneau, C., Mintern, J. D., Hubert, F., Hurt, A. C., Besra, G. S., Porcelli, S. A., Barr, I., Doherty, P. C., Godfrey, D. I., & Turner, S. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813309106 · Cited by 127 · see citing works

Peroxisome Proliferator-Activated Receptor γ Control of Dendritic Cell Function Contributes to Development of CD4+ T Cell Anergy

Klotz, L., Dani, I., Edenhofer, F., Nolden, L., Evert, B., Paul, B., Kolanus, W., Klockgether, T., Knolle, P., & Diehl, L. (2007) · Journal of Immunology · doi:10.4049/jimmunol.178.4.2122 · Cited by 125 · see citing works

Rat PPARs: Quantitative Analysis in Adult Rat Tissues and Regulation in Fasting and Refeeding

Escher, P. (2001) · Endocrinology · doi:10.1210/en.142.10.4195 · Cited by 118 · see citing works

Sumoylation of Peroxisome Proliferator-Activated Receptor γ by Apoptotic Cells Prevents Lipopolysaccharide-Induced NCoR Removal from κB Binding Sites Mediating Transrepression of Proinflammatory Cytokines

Jennewein, C., Kühn, A., Schmidt, M. V., Meilladec-Jullig, V., von Knethen, A., Gonzalez, F. J., & Brüne, B. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5646 · Cited by 110 · see citing works

Regulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases?

Becker, J., Delayre‐Orthez, C., Frossard, N., & Pons, F. (2006) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2006.00425.x · Cited by 109 · see citing works

Deletion of PPARγ in Alveolar Macrophages Is Associated with a Th-1 Pulmonary Inflammatory Response

Malur, A., McCoy, A. J., Arce, S., Barna, B. P., Kavuru, M. S., Malur, A. G., & Thomassen, M. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803504 · Cited by 108 · see citing works

Influenza Morbidity and Mortality in Elderly Patients Receiving Statins: A Cohort Study

Kwong, J. C., Li, P., & Redelmeier, D. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008087 · Cited by 106 · see citing works

The effect of statin therapy on infection-related mortality in patients with atherosclerotic diseases*

Almog, Y., Novack, V., Eisinger, M., Porath, A., Novack, L., & Gilutz, H. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000253397.42079.d5 · Cited by 104 · see citing works

Increased Survival after Gemfibrozil Treatment of Severe Mouse Influenza

Budd, A. C., Alleva, L. M., Alsharifi, M., Koskinen, A. M. L., Smythe, V., Müllbacher, A., Wood, J. T., & Clark, I. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00219-07 · Cited by 101 · see citing works

the Peroxisome Proliferator-Activated Receptor γ Ligand Rosiglitazone Delays the Onset of Inflammatory Bowel Disease in Mice With Interleukin 10 Deficiency

Lytle, C. Y., Tod, T. J., Vo, K. T., Lee, J. W., Atkinson, R., & Straus, D. S. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000160805.46235.eb · Cited by 99 · see citing works

Sepsis-induced inhibition of neutrophil chemotaxis is mediated by activation of peroxisome proliferator-activated receptor-γ

Reddy, R. C., Narala, V. R., Keshamouni, V. G., Milam, J. E., Newstead, M. W., & Standiford, T. J. (2008) · Blood · doi:10.1182/blood-2007-12-128967 · Cited by 99 · see citing works

Defense against Influenza A Virus Infection: Essential Role of the Chemokine System

Kaufmann, A. M., Salentin, R., Meyer, R. G., Bussfeld, D., Pauligk, C., Fesq, H., Hofmann, P., Nain, M., Gemsa, D., & Sprenger, H. (2001) · Immunobiology · doi:10.1078/0171-2985-00099 · Cited by 96 · see citing works

Confronting an influenza pandemic with inexpensive generic agents: can it be done?

Fedson, D. S. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70070-7 · Cited by 94 · see citing works

Confronting the next influenza pandemic with anti‐inflammatory and immunomodulatory agents: why they are needed and how they might work

Fedson, D. S. (2009) · Influenza and Other Respiratory Viruses · doi:10.1111/j.1750-2659.2009.00090.x · Cited by 93 · see citing works

Roles of Apoptosis in Airway Epithelia

Tesfaigzi, Y. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0014oc · Cited by 86 · see citing works

Sequestration of inhaled particulate antigens by lung phagocytes. A mechanism for the effective inhibition of pulmonary cell-mediated immunity.

MacLean, J. A., Xia, W., Pinto, C. E., Zhao, L.-H., Liu, H., & Kradin, R. L. (1996) · Europe PMC (PubMed Central) · Cited by 83 · see citing works

Influenza A virus-induced apoptosis in bronchiolar epithelial (NCI-H292) cells limits pro-inflammatory cytokine release

Brydon, E. W. A., Smith, H. C., & Sweet, C. (2003) · Journal of General Virology · doi:10.1099/vir.0.18913-0 · Cited by 83 · see citing works

After Delays, WHO Agrees: The 2009 Pandemic Has Begun

Cohen, J. D., & Enserink, M. (2009) · Science · doi:10.1126/science.324_1496 · Cited by 82 · see citing works

CXCR2 Is Required for Neutrophil Recruitment to the Lung during Influenza Virus Infection, But Is Not Essential for Viral Clearance

Wareing, M. D., Shea, A. L., Inglis, C. A., Dias, P. B., & Sarawar, S. R. (2007) · Viral Immunology · doi:10.1089/vim.2006.0101 · Cited by 82 · see citing works

Influenza virus antigenic variation, host antibody production and new approach to control epidemics

Chen, J., & Deng, Y. (2009) · Virology Journal · doi:10.1186/1743-422x-6-30 · Cited by 71 · see citing works

Deactivation of murine alveolar macrophages by peroxisome proliferator-activated receptor-γ ligands

Reddy, R. C., Keshamouni, V. G., Jaigirdar, S. H., Zeng, X., Leff, T., Thannickal, V. J., & Standiford, T. J. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00206.2003 · Cited by 71 · see citing works

Inchoate CD8+ T Cell Responses in Neonatal Mice Permit Influenza-Induced Persistent Pulmonary Dysfunction

You, D., Ripple, M. J., Balakrishna, S., Troxclair, D. A., Sandquist, D., Ding, L., Ahlert, T. A., & Cormier, S. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.3486 · Cited by 65 · see citing works

Peroxisome proliferator-activated receptors in macrophage biology: friend or foe?

Moore, K. J., Fitzgerald, M. L., & Freeman, M. W. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200110000-00007 · Cited by 60 · see citing works

Peroxisome proliferator-activated receptors: Bridging metabolic syndrome with molecular nutrition

Guri, A. J., Hontecillas, R., & Bassaganya-Riera, J. (2006) · Clinical Nutrition · doi:10.1016/j.clnu.2006.08.006 · Cited by 56 · see citing works

Peroxisome Proliferator-Activated Receptor-γ Regulates the Expression of Alveolar Macrophage Macrophage Colony-Stimulating Factor

Bonfield, T. L., Thomassen, M. J., Farver, C. F., Abraham, S., Koloze, M., Zhang, X., Mosser, D. M., & Culver, D. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.235 · Cited by 55 · see citing works

Endotoxin downregulates peroxisome proliferator-activated receptor-γ via the increase in TNF-α release

Zhou, M., Wu, R., Dong, W., Jacob, A., & Wang, P. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00340.2007 · Cited by 53 · see citing works

Chemokine regulation of the inflammatory response to a low-dose influenza infection in CCR2–/– mice

Wareing, M. D., Lyon, A. B., Inglis, C. A., Giannoni, F., Charo, I. F., & Sarawar, S. R. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0506299 · Cited by 51 · see citing works

Treatment with a peroxisomal proliferator activated receptor gamma agonist has a modest effect in the allergen challenge model in asthma: A randomised controlled trial

Richards, D. B., Bareille, P. J., Lindo, E. L., Quinn, D., & Farrow, S. N. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2009.11.006 · Cited by 49 · see citing works

Ciglitazone ameliorates lung inflammation by modulating the inhibitor κB protein kinase/nuclear factor-κB pathway after hemorrhagic shock

Chima, R. S., Hake, P. W., Piraino, G., Mangeshkar, P., Denenberg, A. G., & Zingarelli, B. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e318187810e · Cited by 48 · see citing works

Increased Antigen Cross-Presentation but Impaired Cross-Priming after Activation of Peroxisome Proliferator-Activated Receptor γ Is Mediated by Up-Regulation of B7H1

Klotz, L., Hucke, S., Thimm, D., Claßen, S., Gaarz, A., Schultze, J. L., Edenhofer, F., Kurts, C., Klockgether, T., Limmer, A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804260 · Cited by 42 · see citing works

The pathophysiological function of peroxisome proliferator-activated receptor-γ in lung-related diseases

Huang, T. H.-W., Razmovski‐Naumovski, V., Kota, B. P., Lin, D. S.-H., & Roufogalis, B. D. (2005) · Respiratory Research · doi:10.1186/1465-9921-6-102 · Cited by 38 · see citing works

An inverse relationship between peroxisome proliferator–activated receptor γ and allergic airway inflammation in an allergen challenge model

Kobayashi, M., Thomassen, M. J., Rambasek, T., Bonfield, T. L., Raychaudhuri, B., Malur, A., Winkler, A. R., Barna, B. P., Goldman, S. J., & Kavuru, M. S. (2005) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)61173-8 · Cited by 37 · see citing works

Peroxisome-proliferator-activated receptor-γ agonists inhibit the release of proinflammatory cytokines from RSV-infected epithelial cells

Arnold, R., & König, W. (2005) · Virology · doi:10.1016/j.virol.2005.11.009 · Cited by 36 · see citing works

Peroxisome proliferator‐activated receptor‐γ agonists inhibit respiratory syncytial virus‐induced expression of intercellular adhesion molecule‐1 in human lung epithelial cells

Arnold, R., Neumann, M., & König, W. (2007) · Immunology · doi:10.1111/j.1365-2567.2006.02539.x · Cited by 29 · see citing works

Mechanisms Mediating Reduced Responsiveness of Neonatal Neutrophils to Lipoxin A4

Weinberger, B. I., Quizon, C., Vetrano, A. M., Archer, F. E., Laskin, J. D., & Laskin, D. L. (2008) · Pediatric Research · doi:10.1203/pdr.0b013e318180e4af · Cited by 27 · see citing works

Peroxisome proliferator-activated receptor-γ agonists inhibit the replication of respiratory syncytial virus (RSV) in human lung epithelial cells

Arnold, R., & König, W. (2006) · Virology · doi:10.1016/j.virol.2006.03.008 · Cited by 22 · see citing works

Analysis of a Tissue-Specific Enhancer: ARF6 Regulates Adipogenic Gene Expression

(1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.7.3313-.1992 · Cited by 22 · see citing works

Peroxisome Proliferator-Activated Receptors: The Nutritionally Controlled Molecular Networks that Integrate Inflammation, Immunity and Metabolism

Bassaganya-Riera, J., Guri, A. J., King, J., & Hontecillas, R. (2005) · Current Nutrition & Food Science · doi:10.2174/1573401054022619 · Cited by 17 · see citing works

Cheaper approaches to flu divide researchers

Butler, D. (2007) · Nature · doi:10.1038/448976b · Cited by 11 · see citing works

Influenza therapies: vaccines and antiviral drugs

Quigley, E. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.04.010 · Cited by 11 · see citing works

Statin Protection Against Influenza and COPD Mortality

Fedson, D. S. (2007) · CHEST Journal · doi:10.1378/chest.07-0992 · Cited by 6 · see citing works

Invited commentary on David Fedson’s article

Clark, I. A., & Alleva, L. M. (2009) · Influenza and Other Respiratory Viruses · doi:10.1111/j.1750-2659.2009.00098.x · Cited by 2 · see citing works

Into the Eye of the Cytokine Storm

Tisoncik, J. R., Korth, M. J., Simmons, C. P., Farrar, J., Martin, T. R., & Katze, M. G. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05015-11 · Cited by 1,940 · see citing works

The cytokine storm of severe influenza and development of immunomodulatory therapy

Liu, Q., Zhou, Y., & Yang, Z. (2015) · Cellular and Molecular Immunology · doi:10.1038/cmi.2015.74 · Cited by 714 · see citing works

Innate Immune Function and Mortality in Critically Ill Children With Influenza

Hall, M. W., Geyer, S. M., Guo, C., Panoskaltsis‐Mortari, A., Jouvet, P. A., Ferdinands, J. M., Shay, D. K., Nateri, J., Greathouse, K. C., Sullivan, R., et al. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e318267633c · Cited by 154 · see citing works

The inflammatory response triggered by Influenza virus: a two edged sword

Tavares, L. P., Teixeira, M. M., & Garcia, C. C. (2016) · Inflammation Research · doi:10.1007/s00011-016-0996-0 · Cited by 142 · see citing works

Curcumin attenuates angiogenesis in liver fibrosis and inhibits angiogenic properties of hepatic stellate cells

Zhang, F., Zhang, Z., Chen, L., Kong, D., Zhang, X., Lu, C., Lu, Y., & Zheng, S. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12286 · Cited by 135 · see citing works

Immunomodulatory therapy for severe influenza

Darwish, I., Mubareka, S., & Liles, W. C. (2011) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.56 · Cited by 128 · see citing works

The potential of cannabidiol in the COVID‐19 pandemic

Esposito, G., Pesce, M., Seguella, L., Sanseverino, W., Lu, J., Corpetti, C., & Sarnelli, G. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15157 · Cited by 118 · see citing works

Inflammatory Mechanisms of Diabetes and Its Vascular Complications

Nedosugova, L. V., Markina, Y. V., Бочкарева, Л. А., Кузина, И. А., Petunina, N. A., Yudina, I. Y., & Kirichenko, T. V. (2022) · Biomedicines · doi:10.3390/biomedicines10051168 · Cited by 133 · see citing works

Pharmacological (or Synthetic) and Nutritional Agonists of PPAR-γ as Candidates for Cytokine Storm Modulation in COVID-19 Disease

Ciavarella, C., Motta, I., Valente, S., & Pasquinelli, G. (2020) · Molecules · doi:10.3390/molecules25092076 · Cited by 119 · see citing works

IgY antibodies for the immunoprophylaxis and therapy of respiratory infections

Abbas, A. T., El-Kafrawy, S. A., Sohrab, S. S., & Azhar, E. I. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1514224 · Cited by 104 · see citing works

Parsing the Role of PPARs in Macrophage Processes

Toobian, D., Ghosh, P., & Katkar, G. D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.783780 · Cited by 106 · see citing works

Potential of natural astaxanthin in alleviating the risk of cytokine storm in COVID-19

Talukdar, J., Bhadra, B., Dattaroy, T., Nagle, V. L., & Dasgupta, S. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110886 · Cited by 104 · see citing works

Nanotechnology for virus treatment

Zhou, J., Krishnan, N., Jiang, Y., Fang, R. H., & Zhang, L. (2020) · Nano Today · doi:10.1016/j.nantod.2020.101031 · Cited by 101 · see citing works

Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside

Zhang, F., Kong, D., Lu, Y., & Zheng, S. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1046-x · Cited by 87 · see citing works

β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19

Jha, N. K., Sharma, C., Hashiesh, H. M., Arunachalam, S., Meeran, M. F. N., Javed, H., Patil, C. R., Goyal, S. N., & Ojha, S. K. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.590201 · Cited by 86 · see citing works

Wild bitter melon (Momordica charantia Linn. var. abbreviata Ser.) extract and its bioactive components suppress Propionibacterium acnes-induced inflammation

Hsu, C., Tsai, T., Li, Y.-Y., Wu, W.-H., Huang, C.-J., & Tsai, P. (2012) · Food Chemistry · doi:10.1016/j.foodchem.2012.05.045 · Cited by 68 · see citing works

The Prostanoid 15-Deoxy-Δ12,14-Prostaglandin-J2 Reduces Lung Inflammation and Protects Mice Against Lethal Influenza Infection

Cloutier, A., Marois, I., Cloutier, D., Verreault, C., Cantin, A. M., & Richter, M. V. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir804 · Cited by 64 · see citing works

Interplay of Opposing Effects of the WNT/β-Catenin Pathway and PPARγ and Implications for SARS-CoV2 Treatment

Vallée, A., Lecarpentier, Y., & Vallée, J.-N. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.666693 · Cited by 58 · see citing works

Inflammatory and oxidative stress in rotavirus infection

Guerrero, C., & Acosta, O. (2016) · World Journal of Virology · doi:10.5501/wjv.v5.i2.38 · Cited by 56 · see citing works

Can Echinacea be a potential candidate to target immunity, inflammation, and infection - The trinity of coronavirus disease 2019

Meeran, M. F. N., Javed, H., Sharma, C., Goyal, S. N., Kumar, S., Jha, N. K., & Ojha, S. K. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e05990 · Cited by 55 · see citing works

Potential of cell-penetrating peptides (CPPs) in delivery of antiviral therapeutics and vaccines

Sadeghian, I., Heidari, R., Sadeghian, S., Raee, M. J., & Negahdaripour, M. (2021) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2021.106094 · Cited by 54 · see citing works

TMEM43-S358L mutation enhances NF-κB-TGFβ signal cascade in arrhythmogenic right ventricular dysplasia/cardiomyopathy

Zheng, G., Jiang, C., Li, Y., Yang, D., Ma, Y., Zhang, B., Li, X., Zhang, P., Hu, X., Zhao, X., et al. (2019) · Protein & Cell · doi:10.1007/s13238-018-0563-2 · Cited by 48 · see citing works

Targeting inflammatory cytokine storm to fight against COVID-19 associated severe complications

Hirawat, R., Saifi, M. A., & Godugu, C. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118923 · Cited by 47 · see citing works

ssRNA Virus and Host Lipid Rearrangements: Is There a Role for Lipid Droplets in SARS-CoV-2 Infection?

Pagliari, F., Marafioti, M. G., Genard, G. C., Candeloro, P., Viglietto, G., Seco, J. C., & Tirinato, L. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.578964 · Cited by 43 · see citing works

COVID-19: Diabetes Perspective—Pathophysiology and Management

Dallavalasa, S., Tulimilli, S. V., Janhavi, P., Ramachandra, R., Madhunapantula, S. V., & Veeranna, R. P. (2023) · Pathogens · doi:10.3390/pathogens12020184 · Cited by 41 · see citing works

Gamma-oryzanol as a potential modulator of oxidative stress and inflammation via PPAR-y in adipose tissue: a hypothetical therapeutic for cytokine storm in COVID-19?

Francisqueti‐Ferron, F. V., Garcia, J. L., Ferron, A. J. T., Nakandakare-Maia, E. T., Gregolin, C. S., Silva, J. P. D. C., dos Santos, K. C., Lo, Â. T. C., Siqueira, J. S., de Mattei, L., et al. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.111095 · Cited by 38 · see citing works

Discovery of new nanomolar peroxisome proliferator-activated receptor γ activators via elaborate ligand-based modeling

Al-Najjar, B. O., Wahab, H. A., Muhammad, T. S. T., Shu‐Chien, A. C., Noruddin, N. A. A., & Taha, M. O. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.03.040 · Cited by 36 · see citing works

Perspectives of Antidiabetic Drugs in Diabetes With Coronavirus Infections

Sun, B., Huang, S., & Zhou, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.592439 · Cited by 36 · see citing works

The role of influenza A virus-induced hypercytokinemia

Wei, F., Gao, C., & Wang, Y. (2021) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2021.1960482 · Cited by 34 · see citing works

Peroxisome Proliferator-Activated Receptor-Targeted Therapies: Challenges upon Infectious Diseases

Kim, I. S., Silwal, P., & Jo, E. (2023) · Cells · doi:10.3390/cells12040650 · Cited by 33 · see citing works

Telmisartan Restricts Chikungunya Virus Infection In Vitro and In Vivo through the AT1/PPAR-γ/MAPKs Pathways

De, S., Mamidi, P., Ghosh, S., Keshry, S. S., Mahish, C., Pani, S. S., Laha, E., Ray, A., Datey, A., Chatterjee, S., et al. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01489-21 · Cited by 32 · see citing works

CB2 receptor‐selective agonists as candidates for targeting infection, inflammation, and immunity in SARS‐CoV ‐2 infections

Meeran, M. F. N., Sharma, C., Goyal, S. N., Kumar, S., & Ojha, S. K. (2020) · Drug Development Research · doi:10.1002/ddr.21752 · Cited by 30 · see citing works

Role of Fat-Soluble Vitamins A and D in the Pathogenesis of Influenza: A New Perspective

Mawson, A. R. (2012) · ISRN Infectious Diseases · doi:10.5402/2013/246737 · Cited by 26 · see citing works

Untargeted Metabolic Profiling of Extracellular Vesicles of SARS-CoV-2-Infected Patients Shows Presence of Potent Anti-Inflammatory Metabolites

Alzahrani, F. A., Mohammed, M. R. S., Alkarim, S., Azhar, E. I., El‐Magd, M. A., Hawsawi, Y. M., Abdulaal, W. H., Yusuf, A., Alhatmi, A., Albiheyri, R. S., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910467 · Cited by 26 · see citing works

Classical swine fever virus NS5A protein localizes to endoplasmic reticulum and induces oxidative stress in vascular endothelial cells

He, L., Zhang, Y., Lin, Z., Li, W., Wang, J., & Li, H. (2012) · Virus Genes · doi:10.1007/s11262-012-0773-2 · Cited by 26 · see citing works

Peroxisome proliferator-activated receptor-γ interrupts angiogenic signal transduction via transrepression of platelet-derived growth factor-β receptor in hepatic stellate cells

Zhang, F., Kong, D., Chen, L., Zhang, X., Lian, N., Zhu, X., Lu, Y., & Zheng, S. (2013) · Journal of Cell Science · doi:10.1242/jcs.128306 · Cited by 26 · see citing works

Use of pioglitazone in people with type 2 diabetes mellitus with coronavirus disease 2019 (COVID-19): Boon or bane?

Mukherjee Jagat, J., Gangopadhyay, K. K., & Ray, S. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.06.015 · Cited by 26 · see citing works

Toward the Integration of Personalized and Systems Medicine: Challenges, Opportunities and Approaches

Yan, Q. (2010) · Personalized Medicine · doi:10.2217/pme.10.77 · Cited by 26 · see citing works

Therapy of Type 2 Diabetes in Patients with SARS-CoV-2 Infection

Bielka, W., Przezak, A., & Pawlik, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147605 · Cited by 22 · see citing works

Inhibition of rotavirus infection in cultured cells by N-acetyl-cysteine, PPARγ agonists and NSAIDs

Guererero, C. A., Murillo, A., & Acosta, O. (2012) · Antiviral Research · doi:10.1016/j.antiviral.2012.06.011 · Cited by 22 · see citing works

Anti‐influenza A Virus Effects and Mechanisms of Emodin and Its Analogs via Regulating PPARα/γ‐AMPK‐SIRT1 Pathway and Fatty Acid Metabolism

Bei, Y., Tia, B., Li, Y., Guo, Y., Deng, S., Huang, R., Zeng, H., Li, R., Wang, G., & Dai, J. (2021) · BioMed Research International · doi:10.1155/2021/9066938 · Cited by 22 · see citing works

Peroxisome proliferator-activated receptor (PPAR α/γ) agonists as a potential target to reduce cardiovascular risk in diabetes

Nicholls, S. J., & Uno, K. (2012) · Diabetes and Vascular Disease Research · doi:10.1177/1479164112441477 · Cited by 21 · see citing works

Tocilizumab-coated solid lipid nanoparticles loaded with cannabidiol as a novel drug delivery strategy for treating COVID-19: A review

Zielińska, A., Eder, P., Karczewski, J., Szalata, M., Hryhorowicz, S., Wielgus, K., Szalata, M., Dobrowolska, A., Atanasov, A. G., Słomski, R., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1147991 · Cited by 21 · see citing works

Fuzheng Xiaozheng prescription relieves rat hepatocellular carcinoma through improving anti-inflammation capacity and regulating lipid related metabolisms

Li, X., Yu, H., Gong, Y., Wu, P., Feng, Q., & Liu, C. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114801 · Cited by 19 · see citing works

Targeting Peroxisome Proliferator-Activated Receptor-Gamma Decreases Host Mortality After Influenza Infection in Obese Mice

Huang, S., Jiang, L., Cheon, I. S., & Sun, J. (2019) · Viral Immunology · doi:10.1089/vim.2019.0016 · Cited by 18 · see citing works

Lanthionine Synthetase C-Like 2 Modulates Immune Responses to Influenza Virus Infection

Leber, A. J., Bassaganya-Riera, J., Tubau‐Juni, N., Zoccoli-Rodriguez, V., Lu, P., Godfrey, V., Kale, S. D., & Hontecillas, R. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00178 · Cited by 18 · see citing works

Pioglitazone, PPARγ Agonist, Attenuates Experimental Autoimmune Neuritis

Ramkalawan, H., Wang, Y., Ameet, H., Yang, Y., Tian, F., Zhou, W., Li, J., Yang, H., Xiao, B., & Zhang, W. (2012) · Inflammation · doi:10.1007/s10753-012-9447-4 · Cited by 16 · see citing works

Inhibition of rotavirus ECwt infection in ICR suckling mice by N-acetylcysteine, peroxisome proliferator-activated receptor gamma agonists and cyclooxygenase-2 inhibitors

Guerrero, C., Pardo, V. R. P., & Guerrero, O. A. R. (2013) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-0276108062013011 · Cited by 15 · see citing works

Effects of PPAR-γ Agonist Treatment on LPS-Induced Mastitis in Rats

Ding, M., Ming, X., Liu, Y., Piao, T., Lei, X., & Liu, M. (2014) · Inflammation · doi:10.1007/s10753-014-9924-z · Cited by 14 · see citing works

Influenza virus causes lung immunopathology through down-regulating PPARγ activity in macrophages

Zhang, H., Alford, T., Liu, S., Zhou, D., & Wang, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.958801 · Cited by 13 · see citing works

Attenuating influenza a virus infection by heparin binding EGF-like growth factor

Lai, K. M., Goh, B. H., & Lee, W.-L. (2020) · Growth Factors · doi:10.1080/08977194.2021.1895144 · Cited by 12 · see citing works

The PPAR-γ agonist pioglitazone exerts proinflammatory effects in bronchial epithelial cells during acute Pseudomonas aeruginosa pneumonia

Ferreira, B. L., Ramirez‐Moral, I., Otto, N. A., Salomão, R., de Vos, A. F., & van der Poll, T. (2022) · Clinical & Experimental Immunology · doi:10.1093/cei/uxab036 · Cited by 13 · see citing works

PPARs in Clinical Experimental Medicine after 35 Years of Worldwide Scientific Investigations and Medical Experiments

Skoczyńska, A., Ołdakowska, M., Dobosz, A., Adamiec, R., Gritskevich, S., Jonkisz, A., Lebioda, A., Adamiec-Mroczek, J., Małodobra-Mazur, M., & Dobosz, T. (2024) · Biomolecules · doi:10.3390/biom14070786 · Cited by 12 · see citing works

Emerging roles of peroxisome proliferator-activated receptors in the pituitary gland in female reproduction

Shiue, Y., Chen, L.-R., Tsai, C.-J., Yeh, C.-Y., & Huang, C.-T. (2013) · Biomarkers and Genomic Medicine · doi:10.1016/j.gmbhs.2013.04.008 · Cited by 12 · see citing works

Influenza A Immunomics and Public Health Omics: The Dynamic Pathway Interplay in Host Response to H1N1 Infection

Dimitrakopoulou, K., Dimitrakopoulos, G. Ν., Wilk, E., Tsimpouris, C., Sgarbas, K., Schughart, K., & Bezerianos, A. (2014) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2013.0062 · Cited by 12 · see citing works

The role of transcription factor Ap1 in the activation of the Nrf2/ARE pathway through TET1 in diabetic nephropathy

Tan, Y., Cao, H., Li, Q., & Jianjun, S. (2021) · Cell Biology International · doi:10.1002/cbin.11599 · Cited by 11 · see citing works

Gene expression profiling of host lipid metabolism in SARS-CoV-2 infected patients: a systematic review and integrated bioinformatics analysis

Munawar, W. A. S. W. A., Elias, M. H., Addnan, F. H., Hassandarvish, P., AbuBakar, S., & Roslan, N. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-08983-0 · Cited by 8 · see citing works

Dietary plant extracts modulate gene expression profiles in alveolar macrophages of pigs experimentally infected with porcine reproductive and respiratory syndrome virus

Kim, K., Ji, P., Song, M., Che, T. M., Bravo, D., Pettigrew, J. E., & Liu, Y. (2020) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-020-00475-w · Cited by 8 · see citing works

Promising Targeted Therapies for Hemophagocytic Lymphohistiocytosis: A Translational Perspective Based on Immunopathology

Yang, Y., Tu, S., Peng, H., Lu, J., Yu, H., Zhou, Y., Dong, X., & Li, F. (2025) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-025-09068-9 · Cited by 8 · see citing works

Discovering Venom-Derived Drug Candidates Using Differential Gene Expression

Romano, J. D., Li, H., Napolitano, T., Realubit, R. B., Karan, C., Holford, M., & Tatonetti, N. P. (2023) · Toxins · doi:10.3390/toxins15070451 · Cited by 7 · see citing works

Comparative neuroprotective effects of methylprednisolone and rosiglitazone, a peroxisome proliferator-activated receptor-γ following spinal cord injury

Zhang, Q., Huang, C. Y., Tang, T., Shi, Q., & Yang, H. (2011) · Neurosciences · doi:10.17712/1658-3183.1832 · Cited by 7 · see citing works

Unlocking secrets: lipid metabolism and lipid droplet crucial roles in SARS-CoV-2 infection and the immune response

Soares, V. C., Dias, S. D. S. G., Santos, J. C., & Bozza, P. T. (2024) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiae170 · Cited by 6 · see citing works

Rosiglitazone protects diabetic rats from liver destruction.

Lu, Y., Ye, T., Chen, Y., Yu, J., Zhao, L.-J., Wang, N.-J., Jiang, B.-R., Qiao, J., & Yang, L.-Z. (2011) · PubMed · doi:10.3275/7873 · Cited by 5 · see citing works

IMPACT OF ANTIDIABETIC DRUGS ON RISK AND OUTCOME OF COVID-19 INFECTION: A REVIEW

Zainal, A. A., & Merkhan, M. M. (2022) · Military Medical Science Letters · doi:10.31482/mmsl.2022.004 · Cited by 4 · see citing works

Development of mode of action networks related to the potential role of PPARγ in respiratory diseases

Sharif, M. A. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105821 · Cited by 3 · see citing works

Promising role of peroxisome proliferator-activated receptors in respiratory disorders, a review

Beigoli, S., Kiani, S., Asgharzadeh, F., Memarzia, A., & Boskabady, M. H. (2024) · Drug Metabolism Reviews · doi:10.1080/03602532.2024.2442012 · Cited by 3 · see citing works

Current Work and Future Possibilities for the Management of Severe Influenza: Using Immunomodulatory Agents that Target the Host Response

Alleva, L. M., Gualano, R. C., & Clark, I. A. (2011) · Future Virology · doi:10.2217/fvl.11.51 · Cited by 3 · see citing works

Obesidade e infecção por SARS-CoV-2: papel da metainflamação

Albertoni, A. L. D. S., Albertoni, L. G. D. S., & de Almeida, P. E. (2021) · HU Revista · doi:10.34019/1982-8047.2020.v46.32241 · Cited by 1 · see citing works

Targeting Host Factors of virus-induced Inflammation: A Strategy for Tackling Future Epidemics by Rna Viruses

Subudhi, B. B., Chattopadhyay, S., & Chattopadhyay, S. (2022) · Future Virology · doi:10.2217/fvl-2021-0218 · Cited by 1 · see citing works

Role of Peroxisome Proliferator‐Activated Receptors in Inflammation and Angiogenesis

Acharya, S. (2017) · doi:10.1002/9783527697274.ch15

Systems Immunology Approaches for Precision Medicine

Leber, A. J. (2017) · VTechWorks (Virginia Tech)

Nuclear Hormone Receptors and Host-Virus Interactions

Ahmed, N., Ahmed, N. T., Filip, R., & Pezacki, J. P. (2021) · Springer eBooks · doi:10.1007/978-3-030-78315-0_13

Antiviral Activities of Cannabis

Ross, I. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-35155-6_13

Thermogenesis dynamics and influenza A virus: unveiling the intriguing interplay

Park, E., Marakkalage, K. G., & Kim, K. (2025) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2025.2545217

Additional file 1 of Gene expression profiling of host lipid metabolism in SARS-CoV-2 infected patients: a systematic review and integrated bioinformatics analysis

Munawar, W. A. S. W. A., Elias, M. H., Addnan, F. H., Hassandarvish, P., AbuBakar, S., & Roslan, N. (2024) · Figshare · doi:10.6084/m9.figshare.26671938

Additional file 2 of Gene expression profiling of host lipid metabolism in SARS-CoV-2 infected patients: a systematic review and integrated bioinformatics analysis

Munawar, W. A. S. W. A., Elias, M. H., Addnan, F. H., Hassandarvish, P., AbuBakar, S., & Roslan, N. (2024) · Figshare · doi:10.6084/m9.figshare.26671941

Additional file 6 of Gene expression profiling of host lipid metabolism in SARS-CoV-2 infected patients: a systematic review and integrated bioinformatics analysis

Munawar, W. A. S. W. A., Elias, M. H., Addnan, F. H., Hassandarvish, P., AbuBakar, S., & Roslan, N. (2024) · Figshare · doi:10.6084/m9.figshare.26671953

Additional file 3 of Gene expression profiling of host lipid metabolism in SARS-CoV-2 infected patients: a systematic review and integrated bioinformatics analysis

Munawar, W. A. S. W. A., Elias, M. H., Addnan, F. H., Hassandarvish, P., AbuBakar, S., & Roslan, N. (2024) · Figshare · doi:10.6084/m9.figshare.26671944

Additional file 4 of Gene expression profiling of host lipid metabolism in SARS-CoV-2 infected patients: a systematic review and integrated bioinformatics analysis

Munawar, W. A. S. W. A., Elias, M. H., Addnan, F. H., Hassandarvish, P., AbuBakar, S., & Roslan, N. (2024) · Figshare · doi:10.6084/m9.figshare.26671947

Additional file 5 of Gene expression profiling of host lipid metabolism in SARS-CoV-2 infected patients: a systematic review and integrated bioinformatics analysis

Munawar, W. A. S. W. A., Elias, M. H., Addnan, F. H., Hassandarvish, P., AbuBakar, S., & Roslan, N. (2024) · Figshare · doi:10.6084/m9.figshare.26671950

The anti‑inflammatory activity of 2‑iminothiazolidines: the role of PPARγ and M2 macrophage subpopulations

Mohr, E. T. B., Lubschinski, T. L., Moro, P. A. M., Benvenutti, L., Costa, N. T. C., de Sousa, P. L. P. B., Sá, M. M., Hernandes, M. Z., Milton, F. A., Santin, J. R., et al. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02253-y

WTAP-mediated epitranscriptomic program in alveolar macrophages confers prolonged protection against postinfluenza bacterial pneumoniaPreprint

Ge, Y., Hu, X., Li, Z., Cheng, Y., Chen, R., Wu, H., Qian, Z., Song, W., Huang, J., Zou, Y., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.23.727154

Rewiring the psoriasis–metabolism axis: therapeutic potential of saroglitazar beyond PPAR modulation

Vashisht, K., kumar, D. H., Rana, S., Ashawat, M. S., & Kushawaha, S. K. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02413-0

BindingDB Entry 50033504: Discovery of new nanomolar peroxisome proliferator-activated receptor¿ activators via elaborate ligand-based modeling.

BindingDB (2011) · UC San Diego · doi:10.7270/q2k35v05

Influenza virus causes lung immunopathology through down-regulating PPARγ activity in macrophages

Zhang, H., Alford, T., Liu, S., Zhou, D., & Wang, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.958801 · Cited by 13 · see citing works

Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Suppresses Inflammation and Bacterial Clearance during Influenza-Bacterial Super-Infection

Gopal, R., Mendy, A., Marinelli, M. A., Richwalls, L. J., Seger, P. J., Patel, S., McHugh, K. J., Rich, H. E. A., Grousd, J. A., Forno, E., et al. (2019) · Viruses · doi:10.3390/v11060505 · Cited by 27 · see citing works

Pharmacological (or Synthetic) and Nutritional Agonists of PPAR-γ as Candidates for Cytokine Storm Modulation in COVID-19 Disease

Ciavarella, C., Motta, I., Valente, S., & Pasquinelli, G. (2020) · Molecules · doi:10.3390/molecules25092076 · Cited by 119 · see citing works

Peroxisome-proliferator-activated receptor-γ agonists inhibit the release of proinflammatory cytokines from RSV-infected epithelial cells

Arnold, R., & König, W. (2005) · Virology · doi:10.1016/j.virol.2005.11.009 · Cited by 36 · see citing works

3P-0705 Pioglitazone improves conduit artery endothelial function and decreases plasma CRP level in type 2 diabetes

Martens, F. M. A. C., Visseren, F. L. J., de Koning, E. J. P., & Rabelink, T. J. (2003) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(03)90924-x